Skinvisible Capital Expenditures (CapEx) Growth & History (SKVI)

Skinvisible's capital expenditures (capex) was $4,086 for fiscal 2025.

View full Skinvisible company overview

Skinvisible annual capital expenditures (capex) history

Skinvisible annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$4,086−$5,132−55.67%
20242024-12-31$9,218−$115−1.23%
20232023-12-31$9,333$6,803+268.89%
20222022-12-31$2,530−$18,334−87.87%
20212021-12-31$20,864$4,097+24.43%
20202020-12-31$16,767−$9,349−35.80%
20192019-12-31$26,116

Skinvisible capital expenditures (capex) trends

Over the last five fiscal years, Skinvisible's capital expenditures (capex) decreased from $16,767 to $4,086, a change of −$12,681. The latest reported quarter, Q3 2025, shows $1.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Skinvisible source filings ↗

Community posts

It’s quiet here.

No posts about SKVI yet. Start the conversation.

Write the first post